Genesco Inc. (NYSE:GCO - Get Free Report)'s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $24.65 and traded as high as $26.37. Genesco shares last traded at $25.79, with a volume of 175,041 shares traded.
Analyst Upgrades and Downgrades
GCO has been the topic of a number of analyst reports. Wall Street Zen downgraded Genesco from a "buy" rating to a "hold" rating in a research report on Friday, May 30th. Truist Financial lifted their price objective on Genesco from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Thursday, June 5th. Finally, Jefferies Financial Group reiterated a "hold" rating and set a $24.00 price objective (down previously from $27.00) on shares of Genesco in a research report on Wednesday, May 21st.
View Our Latest Research Report on Genesco
Genesco Stock Performance
The firm has a 50 day simple moving average of $23.18 and a 200-day simple moving average of $24.65. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.91 and a quick ratio of 0.55. The company has a market cap of $278.02 million, a price-to-earnings ratio of -16.53 and a beta of 2.25.
Genesco (NYSE:GCO - Get Free Report) last issued its quarterly earnings data on Wednesday, June 4th. The company reported ($2.05) earnings per share for the quarter, beating analysts' consensus estimates of ($2.09) by $0.04. Genesco had a positive return on equity of 2.22% and a negative net margin of 0.67%. The business had revenue of $473.97 million during the quarter, compared to analysts' expectations of $463.90 million. During the same period in the previous year, the firm posted ($2.10) earnings per share. The company's revenue was up 3.6% on a year-over-year basis. As a group, analysts predict that Genesco Inc. will post 0.94 EPS for the current fiscal year.
Insider Buying and Selling at Genesco
In other news, major shareholder Fund 1 Investments, Llc sold 25,000 shares of Genesco stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $23.26, for a total value of $581,500.00. Following the completion of the sale, the insider directly owned 1,072,850 shares of the company's stock, valued at approximately $24,954,491. The trade was a 2.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 23.11% of the company's stock.
Institutional Investors Weigh In On Genesco
A number of institutional investors have recently modified their holdings of the company. CWM LLC grew its stake in shares of Genesco by 61.5% in the second quarter. CWM LLC now owns 1,365 shares of the company's stock valued at $27,000 after buying an additional 520 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Genesco by 4.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 14,392 shares of the company's stock valued at $616,000 after buying an additional 650 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Genesco by 2.1% during the 1st quarter. Bank of New York Mellon Corp now owns 33,737 shares of the company's stock worth $716,000 after purchasing an additional 702 shares in the last quarter. SummerHaven Investment Management LLC grew its stake in Genesco by 2.4% during the 2nd quarter. SummerHaven Investment Management LLC now owns 31,295 shares of the company's stock worth $616,000 after purchasing an additional 721 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in Genesco during the 4th quarter worth $35,000. 94.51% of the stock is owned by institutional investors and hedge funds.
Genesco Company Profile
(
Get Free Report)
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.